SecBot SecBot

APTOF

Aptose Biosciences Inc.
OTC· Biological Products, (No Diagnostic Substances)· Inc. A6· CIK 0000882361 Biotech & Drug Discovery
—
Short interest
3.2K
−0.3%
Days to cover
2.0
at average volume
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1
Strongest BEARISH Aptose Biosciences Inc. filed a Form 15-12G to terminate its SEC registration under Section 12(g), effective…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • Short sellersSTEADY

    Short interest −0.3% to 3.2K shares. 2.0 days to cover.

Who's buying

13F
Top holderSharesValue
Farther Finance Advisors, LLC10$15.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

last action Mar 2025
Recent actions
DateFirmActionRating
Mar 28, 2025HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Next Q———$0.00
Current Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Jun 30, 2026
3,232
shares short
-0.3%
vs prior settlement
2.0
days to cover
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jul 1, 2026 SEC
Aptose Biosciences Inc. filed a Form 15-12G to terminate its SEC registration under Section 12(g), effective July 1…
15-12G — Impact 7/10
Jun 15, 2026 SEC
Aptose Biosciences presented updated Phase 1/2 TUSCANY trial data for tuspetinib (TUS) triplet therapy in newly…
8-K — Impact 7/10
May 29, 2026 SEC
Aptose Biosciences announced a further delay in closing its arrangement with Hanmi Pharmaceutical, now targeting June…
8-K — Impact 5/10

SecBot reports

5 filings · 2 bullish · 1 bearish · 2 neutral
All APTOF filing & press-release reports (5)